Position in AMGN
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$12,735,760
+$375,270 QoQ
Shares Held
35,170
+0.1% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
1.10%
of 13F equity value
Holder Rank
#474
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NAPLES GLOBAL ADVISORS, LLC holds $87,787,212 across 12 Drug Manufacturers - General names. AMGN ranks #4 (14.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
12,798 | $15,350,306 | |
| 2 | MRK |
Merck & Co., Inc.
|
106,535 | $13,689,747 | |
| 3 | JNJ |
Johnson & Johnson
|
52,184 | $13,253,170 | |
| 4 | AMGN |
Amgen Inc
This page
|
35,170 | $12,735,760 | |
| 5 | ABBV |
AbbVie Inc.
|
48,122 | $12,109,420 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
89,358 | $5,148,807 | |
| 7 | AZN |
Astrazeneca PLC
|
24,721 | $4,687,596 | |
| 8 | NVS |
Novartis AG
|
26,087 | $4,088,354 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,735,760 | 35,170 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $12,360,490 | 35,130 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $11,517,711 | 35,189 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $9,966,175 | 35,316 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $9,824,283 | 35,186 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $10,740,686 | 34,475 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $9,123,963 | 35,006 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $11,009,915 | 34,170 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $10,760,778 | 34,440 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $9,786,294 | 34,420 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $9,869,869 | 34,268 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $9,237,281 | 34,370 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $7,467,420 | 33,634 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $7,806,349 | 32,291 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $8,454,906 | 32,192 | Shares | Sole | 2023-04-17 | |
| 2022-09-30 | $7,185,075 | 31,877 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $7,193,894 | 29,568 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $7,057,516 | 29,185 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $6,237,743 | 27,727 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $5,536,130 | 26,034 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $6,117,393 | 25,097 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $5,992,588 | 24,085 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $5,438,527 | 23,654 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $6,304,438 | 24,805 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $5,811,590 | 24,640 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $4,771,656 | 23,537 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||